Your Article Summary
See Latest ArticlesImmunosuppressive therapy in lung transplantation: state of the art
European Journal of Cardio-Thoracic Surgery, 05/27/09
Korom S et al. - The coming of age of lung transplantation is accompanied by an immunosuppressive armamentarium that has been brought forward from other transplant indications. Widely employed on the basis of few small randomized studies, and mostly single-center experience or empirical expert knowledge, anti-rejection therapeutic strategies in pulmonary transplantation have hardly been rigorously evaluated in large-scale prospective international trials.
Related Articles
The Evolution of Kidney Function After Lung Transplantation: A Retrospective Cohort Study
Transplantation Proceedings, 11/11/09
Relevance Score: 71%
Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09
Relevance Score: 71%
Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09
Relevance Score: 71%
Dismal Lung Transplant Outcomes in Children With Tetralogy of Fallot With Pulmonary Atresia Compared to Eisenmenger Syndrome or Pulmonary Vein Stenosis
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 71%
Approach to a lung transplant biopsy
Journal of Clinical Pathology, 11/10/09
Relevance Score: 70%
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Lung transplantation for pediatric pulmonary hypertension
Progress in Pediatric Cardiology, 12/11/09
Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary Fibrosis
Annals of Internal Medicine, 12/03/09
Lung Allocation Score Predicts Survival in Lung Transplantation Patients With Pulmonary Fibrosis
Annals of Thoracic Surgery, 11/24/09